Fig. 3From: Clinical validation of a novel quantitative assay for the detection of MGMT methylation in glioblastoma patientsSurvival analysis of GBM patients. a Kaplan–Meier OS graph comparing methylation GBM patients to unmethylated classified according to MSP. b Kaplan–Meier PFS graph comparing methylation GBM patients to unmethylated classified according to MSP. c Kaplan–Meier OS graph comparing methylation GBM patients to unmethylated classified according to dp_qMSP. d Kaplan–Meier PFS graph comparing methylation GBM patients to unmethylated classified according to MSPBack to article page